HGHristo Georgiev

Hristo Georgiev

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hristo Georgiev has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    New Glass-Ceramics in the System Ca2SiO4-Ca3(PO4)2—Phase Composition, Microstructure, and Effect on the Cell Viability

    by Irena Mihailova, Petya Dimitrova, Georgi Avdeev, Radostina Ivanova, Hristo Georgiev, Milena Nedkova-Shtipska, Ralitsa Teodosieva, Lachezar Radev

    The CaO-SiO2-P2O5 system is one of the main systems studied aiming for the synthesis of new bioactive materials for bone regeneration. The interest in materials containing calcium-phosphate-silicate phases is determined by their biocompatibility, biodegradability, bioactivity, and osseointegration. The object of the present study is the synthesis by the sol-gel method of biocompatible glass-ceramics in the Ca2SiO4-Ca3(PO4)2 subsystem with the composition 6Ca2SiO4·Ca3(PO4)2 = Ca15(PO4)2(SiO4)6. The phase-structural evolution of the samples was monitored using X-ray diffraction analysis (XRD), Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), energy-dispersive spectroscopy (EDS), and surface area analysis. A powder (20–30 µm) glass-ceramic material containing fine crystalline aggregates of dicalcium silicate and plates of silicon-substituted hydroxyapatite was obtained after heat treatment at 700 °C. After heat treatment at 1200 °C, Ca15(PO4)2(SiO4)6, silicocarnotite Ca5(PO4)2(SiO4), and pseudowollastonite CaSiO3 were identified by XRD, and the particle size varied between 20 and 70 µm. The compact glass-ceramic obtained at 1400 °C contained Ca2SiO4-Ca3(PO4)2 solid solutions with an α-Ca2SiO4 structure as a main crystalline phase. SEM showed the specific morphology of the crystalline phases and illustrated the trend of increasing particle size depending on the synthesis temperature. Effects of the glass-ceramic materials on cell viability of HL-60-derived osteoclast-like cells and on the expression of apoptotic and osteoclast-driven marker suggested that all materials at low concentrations, above 1 µg mL−1, are biocompatible, and S-1400 might have a potential application as a scaffold material for bone regeneration.


  • Open Access

    Study of New Glass–Ceramic and Dense Ceramic Containing Biogenic Hydroxyapatite

    by Tina Tasheva, Albena Yoleva, Janna Mateeva, Hristo Georgiev

    A novel bioactive glass–ceramic was developed using biogenic hydroxyapatite (BHA) synthesized from Rapana venosa (Black Sea) shells and monocalcium phosphate monohydrate [Ca(H2PO4)2·H2O] via solid-state synthesis. The prepared batches were obtained by combining BHA with SiO2, B2O3, and Na2O, melted at 1200 °C and melt-quenched in water to form glass–ceramic materials. Dense biogenic hydroxyapatite-based ceramics were successfully sintered at 1200 °C (2 h hold) using a 25 mass % sintering additive composed of 35 mass % B2O3, 45 mass % SiO2, 10 mass % Al2O3, and 10 mass % Na2O. Structural characterization was carried out using X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), and scanning electron microscopy (SEM). The resulting materials consisted of a well-defined crystalline hydroxyapatite phase [Ca10(PO4)6(OH)2] alongside an amorphous phase. In samples with increased SiO2 and reduced B2O3 content (composition 3), a finely dispersed Na3Ca6(PO4)5 crystalline phase appeared, with a reduced presence of hydroxyapatite. Bioactivity was assessed in simulated body fluid (SBF) after 10 and 20 days of immersion, confirming the material’s ability to support apatite layer formation. The main structural units SiO4, PO4, and BO3 are interconnected through Si–O–Si, B–O–B, P–O–P, and mixed Si–O–Al linkages, contributing to both structural stability and bioactivity.